Pharma fun: The Tipline for 26 February 2019
It is a busy week for antitrust in the pharmaceutical industry. In today’s Tipline, we have coverage of the Federal Trade Commission’s loss in an appeal against Shire ViroPharma and a drugmaker trying to get out of the states’ generic antitrust litigation. On the distribution side, the Department of Justice is seeking final approval for its settlement in the CVS/Aetna merger. GCR USA heads to Capitol Hill today, where the Senate Committee on Finance will question pharmaceutical executives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi. All this has us well-prepared for the inaugural GCR Live Pharmaceuticals event on Thursday.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10